ClinicalTrials.Veeva

Menu
N

Nossa Senhora das Gracas Hospital | Centro de Diabetes Curitiba

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tirzepatide
LY3298176
Metformin
Gliclazide
LY3009104
Retatrutide
Baricitinib
Somapacitan
Dapagliflozin
Sugar

Parent organization

This site is a part of Nossa Senhora das Gracas Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 17 total trials

A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease

The study evaluates the safety of different doses of a new medicine called NNC0519 0130. It also looks into how the medicine may improve kidney funct...

Enrolling
Chronic Kidney Disease
Drug: Placebo
Drug: Semaglutide

The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic sho...

Active, not recruiting
SGA, Turner Syndrome, Noonan Syndrome, ISS
Drug: Norditropin®
Drug: Somapacitan

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigational medi...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to devel...

Begins enrollment in 1 month
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

The purpose of this study is to find out if baricitinib can preserve beta-cell function in participants newly diagnosed with type 1 diabetes. Partici...

Begins enrollment in 3 months
Diabetes Mellitus, Type 1
Drug: Baricitinib
Drug: Placebo

The main purpose of this study is to find out how well and how safely tirzepatide works in adults who have type 1 diabetes and obesity or overweight....

Enrolling
Overweight
Type 1 Diabetes
Drug: Tirzepatide
Drug: Placebo

This study will investigate the effect of tirzepatide on the reduction of morbidity and mortality in adults living with obesity and provide additiona...

Active, not recruiting
Overweight
Obesity
Drug: Placebo
Drug: Tirzepatide
Status recently updated

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and ren...

Enrolling
Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Chronic Kidney Disease (CKD)
Drug: Retatrutide
Drug: Placebo

Trial sponsors

Lilly logo
Novo Nordisk logo
C
A
Organon logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems